Yet another cohort underway…for Pelareorep Todays news, certainly expected. Yet another arm & possible market for Pelareorep to help with cancer treatment.
Vey important read, The N.R. Includes quotes, support & colaborations with the following:
Data safety monitoring board.
Paul Ehrlich Institute ( Germanys regulatory body)
The $5 million grant , from PanCan.
German Cancer Society ( AIO), national & international sponsor & study mangemement company.
obviously oncolytics biotech
Last but not leaste Roche & its lead cancer product. ..Tecentriq.....
We can derive a few things from my brief name dropping.
1. Every single opportunity & agency relationship, neeed to be broadly reviewed by the named agencies.
2. The $5 million grant was a competitive , qualified donation. Meaning oncolyitics biotech/ Pela had to prove it's worthwhile to get that $$ ahead of others.
3. It was stated way way back @ start of Gobblet, " months of internal & investigative due process was conducted, before Roche allowed their good name & lead product Tecentriq to become part of the Gobblet trials.
4. There are 6+ analysts , who specialize in biotech, watching & reporting on ONC clinical results & possible cancer treatment market opportunities.They all BTW are bound to by their professional credentials & accreditations to site all off their comments.
Saying all that...we read & hear clearly that all of those medical, global medical & business professionals are all gullible & being conned by Onc?
I congratulate Bucky on your extream insight & intelligence.
obviously you are the smartest person on this BB, perhaps in the world?
Oh, I forgot to mention the FDA..
They afterall granted fast track designation for MBc & pancreatic cancer treatments using Pela , combined with other co- therapies.
They according to your statements,also must be gullible?
Moving forward to what we know.
They continue to produce favourable results, at various levels. From laboratory , to mutiple phase 2 trials.
They are expected to produce yet more data next ten days at another cancer forum, regarding the trial with Incyte ( I guess they conned them too?).
onc must produce a business deal, very soon.
Everyone knows that.
Regarding shareprice?
Some have touted , reverse split etc, to stay listed on NAS?
I sincerely doubt it!
First, the de- listing of the NAS is potentially months away.
The process is lenghly & well outside of upcoming " milestones "
Second: Mangement is well aware of those working very hard to bash the stock, including the noted increase in shorting.
The last major financing deal was all Canadian, Read into that what you want.
onc has produced major milestones, including in writing self Evaluation of the MBc market @ $2.5 billion/ year.
That was in relative Terms, vert recent.
i know some are all expecting a R/S , to benefit from future sp attacks.
Not going to happen!
They don't need to.
Time will tell.
All the best to everyone.